Biology subjects

Pike, C. J.

Publications and source records attributed to Pike, C. J..

4 recordsLinked to original sources

bioRxiv2026

17α-Estradiol Confers Limited Protection Against APOE4 Phenotypes in Middle-Aged Female Mice

Longevity-promoting interventions represent a promising strategy to mitigate brain aging and reduce Alzheimers disease (AD) risk. The NIA Interventions Testing Program identified the weak estrogen 17-estradiol (17E2) as a compound that extends healthspan and lifespan in mice, with effects observed primarily in males. Our recent work demonstrated that 17E2 healthspan benefits were modulated by human apolipoprotein E (APOE) genotype such that aging phenotypes were improved more strongly in middle-aged male mice with targeted-replacement of the AD-associated APOE4 allele compared to APOE3, the risk neutral and most common APOE allele. Here, we tested whether APOE-dependent, AD-relevant benefits of 17E2 observed in males extend to females. Specifically, we treated 12-month-old APOE3 and APOE4 targeted-replacement female mice for 6 months with chow containing 0 or 14.4ppm 17E2. We find that relative to APOE3, APOE4 genotype largely exhibits more robust systemic phenotypes associated with aging, including increased adiposity, impaired glucose tolerance, and reduced energy expenditure. Further, we observe that treatment with 17E2 yields modest improvements in some outcomes, including decreased adiposity and increased lean mass, glucose tolerance, and energy expenditure, though significant benefits are found only in APOE4 females. In the CNS, we observed mixed effects of APOE genotype on behavioral performance and indices of brain aging, with APOE4 females performing worse in the Barnes Maze and having higher levels of the AD-related peptide soluble {beta}-amyloid, but no APOE genotype differences in cortical lipid raft oxidative damage. In contrast to its systemic effects, 17E2 did not significantly improve neural outcomes in APOE3 or APOE4 females. These findings address the impact of biological sex on established protective effects of a longevity-promoting intervention against APOE4 phenotypes, which have significant relevance to the prevention of age-related conditions including metabolic dysfunction, cognitive impairment and vulnerability to AD.

systems biology↗

bioRxiv2026

Females Adapt to Dietary Protein Restriction on Enhanced Gut-Brain Axis during Aging

Growing evidence supports a critical role for the gut-brain axis in regulating metabolic health, inflammation, and cognitive function during aging. Age-associated gut dysbiosis has been linked to metabolic dysfunction and cognitive decline, with females exhibiting increased susceptibility to these age-related impairments. Diet is a major determinant of gut microbiome composition and function. Previous studies from our laboratory demonstrated that dietary protein restriction (DPR) induces fibroblast growth factor 21 (FGF21), improves metabolic health, and extends lifespan in male mice. However, the effects of DPR on the gut microbiome and associated health outcomes in aged female mice remain poorly understood. Female mice were assigned at 16 months of age to either a normal-protein (NP) or low-protein (LP) diet for 26 weeks. Metabolic assessments included food intake, fasting glucose concentrations, and glucose tolerance testing. Senescence-associated markers in mesenteric white adipose tissue (mWAT), fecal microbiome composition, and behavioral outcomes were evaluated to determine relationships among dietary protein intake, microbial communities, metabolic health, and cognitive function. Low-protein diet significantly improved metabolic health in aged female mice, as evidenced by improved glucose regulation. Microbiome analyses revealed increased abundance of Akkermansia at 17 months and Faecalibaculum in LP-fed animals at 22 months of age. More so, functional profiling and gene set enrichment analyses indicated enrichment of microbial pathways associated with membrane integrity and metal ion binding. Lastly, LP-fed female mice displayed improved memory performance at 22 months of age compared with age-matched NP-fed controls. Collectively, these findings demonstrate that DPR remodels the gut microbiome and improves metabolic and cognitive health in aged female mice. The observed microbial adaptations may contribute to the beneficial effects of DPR on aging-related physiology, highlighting the gut microbiome as a potential mediator of dietary interventions that promote healthy aging.

physiology↗

bioRxiv2024

Protection against APOE4-associated aging phenotypes with the longevity-promoting intervention 17α-estradiol in male mice

The apolipoprotein {varepsilon}4 allele (APOE4) is associated with decreased longevity, increased vulnerability to age-related declines, and disorders across multiple systems. Interventions that promote healthspan and lifespan represent a promising strategy to attenuate the development of APOE4-associated aging phenotypes. Here we studied the ability of the longevity-promoting intervention 17-estradiol (17E2) to protect against age-related impairments in APOE4 versus the predominant APOE3 genotype using early middle-aged mice with knock-in of human APOE alleles. Beginning at age 10 months, male APOE3 or APOE4 mice were treated for 20 weeks with 17E2 or vehicle then compared for indices of aging phenotypes body-wide. Across peripheral and neural measures, APOE4 was associated with poorer outcomes. Notably, 17E2 treatment improved outcomes in a genotype-dependent manner favoring APOE4 mice. These data demonstrate a positive APOE4 bias in 17E2-mediated healthspan actions, suggesting that longevity-promoting interventions may be useful in mitigating deleterious age-related risks associated with APOE4 genotype.

systems biology↗

bioRxiv2024

Microglia/macrophage-specific deletion of TLR-4 protects against neural effects of diet-induced obesity

Obesity is associated with numerous adverse neural effects, including reduced neurogenesis, cognitive impairment, and increased risks for developing Alzheimers disease (AD) and vascular dementia. Obesity is also characterized by chronic, low-grade inflammation that is implicated in mediating negative consequences body-wide. Toll-like receptor 4 (TLR4) signaling from peripheral macrophages is implicated as an essential regulator of the systemic inflammatory effects of obesity. In the brain, obesity drives chronic neuroinflammation that involves microglial activation, however the contributions of microglia-derived TLR4 signaling to the consequences of obesity are poorly understood. To investigate this issue, we first generated mice that carry an inducible, microglia/macrophage-specific deletion of TLR4 that yields long-term TLR4 knockout only in brain indicating microglial specificity. Next, we analyzed the effects of microglial TLR4 deletion on systemic and neural effects of a 16-week of exposure to control versus obesogenic high-fat diets. In male mice, TLR4 deletion generally yielded limited effects on diet-induced systemic metabolic dysfunction but significantly reduced neuroinflammation and impairments in neurogenesis and cognitive performance. In female mice maintained on obesogenic diet, TLR4 deletion partially protected against weight gain, adiposity, and metabolic impairments. Compared to males, females showed milder diet-induced neural consequences, against which TLR4 deletion was protective. Collectively, these findings demonstrate a central role of microglial TLR4 signaling in mediating the neural effects of obesogenic diet and highlight sexual dimorphic responses to both diet and TLR4.

neuroscience↗